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Angina pectoris W Bradykinin W Capsaicin W Pain W Vagus
nerve
Abstract
The awareness in specific brain centers of angina pecto-
ris most often results from ischemic episodes in the
heart. These ischemic episodes induce the release of a
collage of chemicals that activate chemosensitive and
mechanoreceptive receptors in the heart, which in turn
excite receptors of the sympathetic afferent pathways.
Ascending pain signals from these fibers result in the
activation of the brain centers which are involved in the
perception and integration of cardiac pain. Cytochemical
studies of the nervous system provide the opportunity to
identify these areas at the cellular level. In the present
investigation, cardiac nociception was studied in the
brains and the spinal cords of rats, using Fos protein as a
marker of neuronal activation, following the application
of pain-inducing chemicals to the heart. Induction of
myocardial pain in conscious rats was achieved by infu-
sion of bradykinin (0.5 Ìg) or capsaicin (5 Ìg) into the
pericardial sac. During pain stimulation, the rats demon-
strated pain behavior, in conjunction with alterations in
heart rate and blood pressure. The cerebral Fos expres-
sion pattern was studied 2 h after pain stimulation. In
contrast to the control group, increased Fos expression
was found following the use of both capsaicin and brady-
kinin in a variety of areas of the brain. Bradykinin, but not
capsaicin, induced Fos expression in the upper thoracic
and upper cervical spinal cord; these segments are the
sites where cardiac sympathetic fibers terminate. This
finding suggests that these two chemicals use two differ-
ent pathways, and provides extra evidence for the role of
the vagus nerve in the transmission of cardiac nocicep-
tion. Different cerebral areas showed an increase in the
c-fos activity following pericardial application of pain-
inducing chemicals. The role of these cerebral areas in
the integration of cardiac pain is discussed in relation to
the identified pathways which transmit cardiac pain.
Copyright © 2004 S. Karger AG, Basel
Introduction
Patients with ischemic heart disease often seek medical
care when they experience symptoms of chest pain, gener-
ally referred to as angina pectoris. Both physical exercise
and mental stress can induce angina in patients with isch-
emic heart disease. The ‘anginal warning signal’ is propa-
gated to the brain through afferent neural pathways [1].
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Recruitment of these afferent pathways during ischemic
challenges arises from the local release of a variety of com-
pounds, including potassium, lactate, adenosine, bradyki-
nin and prostaglandins [2, 3], which are able to sensitize
high-threshold nerve endings in the heart [4]. The induc-
tion of an inflammatory response further sensitizes affer-
ent nociceptors (i.e., the threshold of the high-threshold
fibers becomes lower) [4, 5]. As a result, it is unlikely that
one chemical will induce anginal pain in vitro. We used
bradykinin or capsaicin. Since these two algesic sub-
stances employ different actions, they can be used to spe-
cify the neural centers that are involved in the perception
and integration of cardiac pain more precisely. Bradyki-
nin is a mediator of inflammatory pain [6] released fol-
lowing ischemia in the myocardium [7], and is used as the
chemical of choice to produce nociceptive responses.
Capsaicin has become a valuable substance for revealing
the function of the afferents. A selective site of action of
capsaicin on polymodal-type nociceptors of the C and A
delta fibers was described by single unit studies, both in
cutaneous nerves and in nerve branches innervating the
heart and the great vessels [8–11].
Intermittent or permanent occlusion of a coronary
artery stimulates chemical and mechanical cardiac recep-
tors which excite sympathetic and vagal afferent fibers.
Both types of fiber are responsible for the first part of the
transmission of afferent information following ischemic
challenges from the heart, and ultimately give rise to the
awareness of pain in the cognitive centers of the brain.
Neuroimaging techniques have enabled researchers to
identify cerebral activation patterns during angina pecto-
ris. However, these techniques provide only rough infor-
mation about different areas in the CNS involved in car-
diac pain. Cytochemical studies of the nervous system
provide the opportunity to identify these areas more pre-
cisely at a cellular level. Therefore, we investigated the
different brain centers involved in the perception and
integration of cardiac pain by administering noxious com-
pounds into the pericardial sacs of conscious rats [12].
Cerebral Fos protein was used as a marker of neuronal
activation. Fos is a transiently expressed immediate early
gene protein used to characterize CNS activity patterns
after painful stimulation. The validity of the use of c-fos as
a marker of neuronal activity has been established pre-
viously [13–18].
The use of animal models enabled us to obtain an
image of the cytoarchitecture and neurochemistry of car-
diac pain processing circuitry. Moreover, such models
provide possibilities to test the physiological and behav-
ioral consequences of pain processing.
Materials and Methods
Animals
Male Wistar rats (250–300 g body weight) were housed in sepa-
rate cages (40 ! 30 ! 30 cm) in a temperature-controlled environ-
ment with a light-dark regimen (12 h dark period), immediately after
the arrival in the laboratory. Harlan (Zeist, The Netherlands) sup-
plied the animals. Food (standard laboratory rat chow) and water
were ad libitum. After a 3-day acclimatization, a permanent pericar-
dial sac catheter was implanted in all animals. Postsurgical recovery
was 7 days and an additional 7 days for animals supplied with tele-
metric (Data Sciences Int.) blood pressure and heart rate monitoring
devices. Apart from the observed weight gain, reappearance of a
diurnal cardiovascular rhythm was an indication of the recovery of
the animals after 7 days.
The local Animal Bio-Ethics Committee (DECnr. 1189) ap-
proved all procedures. Since the experiments were conducted in con-
scious rats, the number of animals used was minimized, conforming
to the guidelines for the use of awake animals in experimental pain
research [19] of the International Society for Pain Research.
Surgery
The rats were preanesthetized in a Perspex chamber (10 ! 20 !
10 cm) with a mixture of halothane, nitric oxide, and oxygen. At an
appropriate level of anesthesia, the animals were removed from the
box to be intubated with a plastic 14-gauge tube (21 ! 45 mm), and
connected to a ventilator (MK2 Infant ventilator, Loosco, Amster-
dam, The Netherlands) that supplied the same anesthetic. Then the
animals were prepared for the surgery. The skull was cleaned for the
fixation of the cannula and the abdominal-thoracic area for an
abdominal-diaphragmatic route of approach to the pericardial sac. A
hole was punched in the pericardial sac to allow the insertion of the
silicon catheter (diameter outside 100 Ìm, inside 50 Ìm). One centi-
meter of the catheter was placed in the pericardial sac and secured to
the pericardial tissue and fat pads with sterile 6/0 silk sutures (BV-1,
Ethicon GmbH, Norderstedt, Germany). In 4 rats, the catheter was
placed in the extrapericardial space to serve as a control for possible
leakage effects. The catheter was tunneled to the head subcutaneous-
ly. A hypodermic needle (25 gauge, 0.5 ! 16 mm), bend 90°, was
placed on the catheter for attachment of the infusion tube. The
device was fixed on the head with dental cement. The abdominal
wounds were closed after securing of the catheter with tissue glue.
Then the animals were detubated and placed on a heating pad for
recovery.
Three rats in every experimental group were reanesthetized after
7 days for the implantation of a telemetric blood pressure recording
device (Data Sciences Int., St. Paul, Minn., USA, type: TA11PA-
C20). In these animals, the descending aorta was exposed and
clamped with a counter-weighted suture at the level of the renal
artery. A hole was punched in the aorta with a sharp hypodermic
needle approximately 5 mm proximal of the decussation. The tip of
the cannula of the recording device was inserted into the descending
aorta and fixed with tissue glue. The telemetric device (2.5 ! 1 !
1 cm) was placed in the abdomen and then the wounds were closed.
Experimental Procedure
The animals were handled daily to reduce stress associated with
the preparation of the experiment. Thirty minutes before the start of
the infusion of the noxious compound, the animals were connected
to the infusion pump (CMA 100 Carnegie Medicine) and placed in
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the observation cage (30 ! 25 ! 30 cm). The behavior was recorded
on video from –30 to 60 min after the start of the infusion. ‘Pain’
behavior was analyzed with dedicated software (Observer 3.0, Nol-
dus Information Technology, Wageningen, The Netherlands). Acute
pain was generated with 50 Ìl of a noxious compound, delivered at a
speed of 2 Ìl/min (CMA 100, Carnegie Medicine).
All animals were terminated after 2.5 h with an intraperitoneal
injection of a 6% sodium pentobarbital solution (2 ml/kg). After
transcardial perfusion with heparinized saline and a 0.2 M phos-
phate-buffered 4% paraformaldehyde solution (pH 7.4), the brain
and spinal cord were removed, postfixed in the same fixative solu-
tion overnight, and then placed in phosphate-buffered saline solution
containing 0.1% sodium azide at 4°C. After cryoprotection in 30%
0.2 M phosphate-buffered sucrose solution (pH 7.4), serial 40-Ìm
coronal sections of the brain and spinal cord were prepared on a cryo-
stat microtome and collected in 0.02 M phosphate-buffered saline
(pH 7.4) with 0.1% sodium azide and stored at 4°C.
Immunohistochemistry
The immunocytochemical procedure for visualization of Fos pro-
tein expression has been described previously [20]. In brief, free
floating sections were preincubated in a 0.02 M potassium phos-
phate-buffered saline solution (KPBS; pH 7.4) containing 2% normal
rabbit serum, and 2% bovine serum albumin during 4 h. Thereafter,
the free-floating sections were incubated with polyclonal sheep anti-
c-Fos (1:2,000; OA-11-824) solution in KPBS containing 2% normal
rabbit serum, 2% bovine serum albumin and 0.3% Triton X-100.
After overnight incubation at room temperature and thorough wash-
ing with KPBS, the sections were incubated with biotinylated rabbit
anti-sheep IgG (1:800 Pierce) solution in KPBS during 4 h. Following
several rinses with KPBS, the incubation was continued in a solution
containing peroxidase-labeled avidin-biotin complex (Vector Labs.)
during 4 h. The presence of peroxidase was revealed with a 0.05%
3,3-diaminobenzidine (Sigma), 2.5% nickel ammonium sulfate,
0.04% ammonium chloride and 0.005% hydrogen peroxide solution.
The diaminobenzidine reaction was stopped after 20 min. Then, the
sections were washed in KPBS and mounted with a gelatin-chrome
alum solution. After dehydration in graded ethanol solutions and
xylene, the material was embedded with Depex.
Quantifications
The number of Fos-positive cells was quantified in a number of
selected brain regions (fig. 3) with an ocular grid (5 ! 5 squares;
400 ! 400 Ìm at a magnification of !125). Different rostro-caudal
levels were defined with the stereotaxic atlas of Swanson [21]. The
number of labeled cells was expressed as left-right mean value, unless
stated otherwise.
Statistics
One-way ANOVA with a Student-Neuman Keuls multiple com-
parison method was used to test the effects of the treatments. Pair-
wise comparisons were performed with a Student t test. The data
were analyzed with the statistical software package Sigmastat® (Jan-
del Scientific, San Rafael, Calif. USA). p ! 0.05 was considered sig-
nificant.
Drugs
Bradykinin (Sigma, St. Louis, Mo., USA) was dissolved in saline
to a concentration of 100 Ìg/ml stock solution. The bradykinin stock
was diluted in 0.2% Evans blue saline 1:10, of which 50 Ìl were
administered into the pericardial sac (effective amount 0.5 Ìg brady-
kinin). Capsaicin was mixed with 10% Tween 80, 10% ethanol, and
80% saline to create a stock solution of 1 mg/ml. Fifty microliters of a
1:10 diluted stock solution in 0.2% Evans blue saline was adminis-
tered (effective amount 5 Ìg capsaicin). These dosages caused noci-
ceptor activation in various experimental designs [6, 20, 22]. Pilot
experiments showed that these amounts induced significant behav-
ioral responses in our design. Evans blue was added to the solutions




The rats showed a typical pain behavior irrespective of
the noxious compound that was administered. Increased
exploration, characterized by escape behavior and
scratching of the chest, forepaw, and neck area, preceded
a long-lasting immobilization in a typical position both
after administration of bradykinin and capsaicin (44 B
9% and 73 B 3% of the observation time for bradykinin
and capsaicin, respectively). During the immobilization,
the chest was pressed firmly to the bottom of the cage and
often the forepaws and hindpaws were extended. Delayed
bradykinin-induced immobilization, which started after
10 min, explains the significant behavior differences be-
tween the capsaicin and bradykinin group with respect to
the time spent on immobilization, exploration, and wake
behaviors (fig. 1). The different behavioral responses also
illustrate that capsaicin not only can generate immediate,
but also stronger adverse effects than bradykinin. Admin-
istration of the noxious compounds into the chest caused
the same behavioral responses and typical pain behavior
(59 B 17% of the observation time). Saline infusions into
the pericardial sac never generated immobilization or
pain behavior.
Cardiovascular Responses
After the attachment of the microinfusion pump,
blood pressure and heart rate values returned to baseline
(heart rate: 345–370 beats/min and mean arterial pres-
sure: 100–110 mm Hg) in approximately 10 min. Brady-
kinin administration was followed by an immediate, but
nonsignificant rise of heart rate, in parallel with a change
of the behavior. Heart rate was elevated for 1 h (fig. 2A)
and then followed by a slight decrease. Capsaicin caused,
despite a strong behavioral response, a slight decrease in
heart rate during the first 20 min (fig. 2C). Ten minutes
after the pump was switched off, the heart rate reached a
maximum of 430 B 25 beats/min.
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Fig. 1. Behavioral responses of animals re-
ceiving saline, bradykinin and capsaicin into
the pericardial sac. The data are expressed as
percentage of time spent during the 35 min
of observation following infusion. Behavior-
al responses of animals receiving bradykinin
in the extrapericardial space (chest) are also
provided. a p ! 0.05: a significant difference
from control. b p ! 0.05: a significant differ-
ence from bradykinin-treated animals. n.s. =
Behavior not shown.
Blood pressure effects of pericardial capsaicin admin-
istration were more pronounced (fig. 2C, D). Three min-
utes after the start of the infusion, capsaicin generated
biphasic hypertension. The mean arterial pressure was
significantly elevated between 7 and 12 min (baseline
mean arterial pressure 105 B 7 mm Hg to peak mean
arterial pressure 131 B 9 mm Hg) and again between 56
and 70 min (peak of 119 B 3 mm Hg). Bradykinin did not
generate significant changes of mean arterial pressure.
Saline infusions into the pericardial sac were not asso-
ciated with significant alterations of blood pressure and
heart rate (data not shown), which is in line with the
observed undisturbed behavior. Control infusions of the
noxious compounds into the chest generated cardiovascu-
lar responses that were compatible with the pericardial
sac infusions (fig. 2).
Bradykinin-Induced Fos Expression
The distribution of Fos-labelled cells in the nervous
system after pericardial administration of saline and bra-
dykinin is presented schematically in figure 3. Column 3
indicates the sites that were quantified.
Increased Fos immunoreactivity (Fos-ir), compared
with the saline-induced expression, was found in the pre-
and infralimbic cortex, the shell of the nucleus accum-
bens, and the dorsal and ventral agranular insular cortex
(fig. 3A). Regionally, the primary motor cortex and the
jaw area of the primary sensory cortex showed an in-
creased Fos-ir. The anterior cingulate cortex (Acg), the
ventrolateral caudate putamen, and the olfactory tubercle
all showed a moderate increase. Rostral hypothalamic
areas showing altered Fos-ir were the ventral bed nucleus
of the stria terminalis, and the medial, ventral and ventro-
lateral parts of the medial preoptic nucleus. The most
impressive increase in Fos-ir in the forebrain was found in
the posterior insular cortex (fig. 4F), in the posterior
agranular and the granular fields (fig. 3B, C). In the senso-
ry and motor cortices and the retrosplenial cortex, we
noted a regionally increased Fos-ir. Other areas exhibiting
a significant Fos-ir were the central amygdala, the para-
ventricular hypothalamic nucleus (PVN; fig. 5B), the dor-
sal and dorsomedial hypothalamus, the perifornical area
and the medial part of the lateral hypothalamus. The
medial amygdala, the medial part of the zona incerta, the
thalamic reuniens and rhomboid nuclei, the centrome-
dial, the paraventricular, and the centrolateral thalamic
nuclei all showed a slightly increased Fos expression. A
significantly increased Fos-ir was found in the auditory,
the temporal association, and the ectorhinal cortices, as
well as in the medial part of the lateral amygdaloid
nucleus. Interestingly, neither saline nor bradykinin in-
duced Fos-ir in the rostral part of the ventral posterolater-
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Fig. 2. Graphs showing effects of the pericardial bradykinin (n = 3) and capsaicin (n = 3) infusions on heart rate and
blood pressure of conscious rats. Significant increases from baseline levels are indicated with an asterisk (p ! 0.05).
A Heart rate (beats/min + SEM) after pericardial bradykinin infusion. B Blood pressure (mm Hg + SEM) after
pericardial bradykinin infusion. C Heart rate (beats/min + SEM) after pericardial capsaicin infusion. D Blood pres-
























































































al thalamic nucleus and in the reticular thalamic nucleus
(fig. 3D).
In the posterior diencephalon (fig. 3E), the parvocellu-
lar part of the subparafascicular nucleus (SFPC), the ven-
tral part of the ventroposterolateral (VPLpc) and ventro-
posteromedial (VPMpc) thalamic nucleus, the adjoining
dorsal part of the zona incerta and the posterior thalamic
nucleus (fig. 4A) were all Fos positive after bradykinin
administration into the pericardial sac. The number of
Fos-ir cells was increased in the intergeniculate leaflet and
the parvocellular ventrolateral geniculate nucleus and
subgeniculate nucleus, and in the pretectal area, the
supramammillary nucleus, the parafascicular thalamic
nucleus, and the dorsolateral part of the posterior lateral
hypothalamus. Fos expression in cortical fields, at this
rostro-caudal level, was moderately increased in the re-
trosplenial gyrus, the secondary visceral cortex, the pari-
etal association cortex, and the primary and secondary
auditory fields. The perirhinal, entorhinal, and ectorhinal
cortex were not affected, but the posteromedial amygdalo-
hippocampal area showed a small increase in Fos-ir.
In the midbrain, Fos expression was increased in var-
ious subregions of the periaqueductal gray (PAG), in par-
ticular the dorsomedial rostral PAG, the dorsolateral and
lateral medial PAG (fig. 6A, B), and the lateral and ven-
trolateral caudal PAG (fig. 3F, G). Other areas showing
increased Fos-ir at this level were the peripeduncular
nucleus, the triangular part of the posterior thalamic
nucleus, the ventrolateral part of the anterior pretectal
nucleus, and the medial part of the superior colliculus. A
low to moderate increased Fos-ir was found in the retro-
splenial gyrus, the secondary visceral field, and in se-
lective parts of the auditory and the temporal association
cortex. Bradykinin increased Fos expression in the ven-
trolateral pontine reticular formation. The Kölliker-Fuse
nucleus, the pons, the locus coeruleus (LC), the dorsal and
lateral parabrachial nuclei, the ventrolateral reticular A5
area, the raphe magnus and the lateroventral periolivary
nucleus all showed increased Fos-ir at the pontomedullary
level. Regionally, the treatment affected Fos-ir in the prin-
cipal spinal trigeminal nucleus (fig. 3H) and the ventral
cochlear nucleus.
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Abbreviations used in figures 3, 4, 6, and 7





Acg anterior cingulate cortex
AI agranular insular cortex
AIP (aip) posterior agranular insular cortex
AMB (amb) ambiguus nucleus
Amyg amygdala
APT anterior pretectal nucleus
Au auditory cortex
BST bed nucleus stria terminalis
cc cingulate cortex




Cu (cu) cuneate nucleus
DC dorsal cochlear nucleus
di dysgranular insular cortex
dr dorsal periaqueductal grey
Dtg dorsal tegmentum
Ect ectorhinal cortex






IML intermediolateral cell group
Irt intermediate reticular nucleus
Lfu lateral funiculus
LG lateral geniculate nucleus
Li linear medulla nucleus
LL lateral lemniscus
LPb lateral parabrachial nucleus
Lrt lateral reticular nucleus
LS lateral septum
LSO lateral superior olive nucleus
M1 primary motor cortex field
M2 secondary motor cortex field
md dorsomedial thalamus
MdD dorsal medullary reticular nucleus
MdV ventral medullary reticular nucleus
ml mediolateral thalamus
mg medial geniculate nucleus
Mve medial vestibular nucleus
NTS solitary tract nucleus
P5 principal spinal trigeminal nucleus
PAG (pag) periaqueductal gray
Pb parabrachial nucleus
PCRt (pcrt) parvocellular reticular formation




PnO oral pontine nucleus
Po (po) posterior thalamus nucleus
PRF pontine reticular formation
Py pyramidal tract
RE reuniens thalamic nucleus
RMG raphe magnus nucleus
RSA retrosplenial cortex
RtT reticular tegmental nucleus
RVL rostroventrolateral medulla oblongata
S subiculum
S1 primary somatosensory cortex field
S1BF primary somatosensory barrel field area
s2 sensory optic nerve
S5 sensory trigeminal nerve
SC superior colliculus
scp superior cerebellar peduncle
Sp5 (sp5c) spinal trigeminal nucleus
Sp5c caudal spinal trigeminal nucleus
SS somatosensory cortex field
ts tractus solitarius
V2 secondary visual cortex
vl pag ventrolateral periaqueductal grey
VPL (vpl) ventroposterolateral thalamus nucleus
vpm ventroposteromedial thalamus
vppc ventroposterior parvocellular thalamic nucleus
vm ventromedial thalamic nucleus
ZI (zi) zona incerta
II lamina II of Rexed
III lamina III of Rexed
V lamina V of Rexed
VII lamina VII of Rexed
Fig. 3. Series of coronal hemisections of the rat brain illustrating, from rostral (A) to caudal
(L), the locations of Fos-ir cells in saline- and bradykinin-treated animals. M Fos expression
in the second thoracic segment is shown. Column 3 gives the names of the affected structures
and indicates the location of regions in which the Fos expression was quantified (data in
table 1).
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Fig. 4. Photomicrographs showing Fos expression in the caudal ventrolateral thalamus (A, B), the medial thalamus
(C), and the insular cortex (D, E, F). A, B, F The pattern of Fos-ir after infusion of bradykinin in the pericardial sac.
C, D Obtained from animals treated with capsaicin. E From a saline-treated animal. Note the selective labeling
pattern in the granular insular field (F) after pericardial bradykinin infusion and the more generalized labeling in the
same and adjoining cortical fields after capsaicin treatment (D).
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Fig. 5. Photomicrographs illustrating Fos-ir in the hypothalamic paraventricular nucleus after pericardial infusions of
saline (A), bradykinin (B) and capsaicin (C).
Fig. 6. Photomicrographs of Fos-ir in the ventrolateral PAG of bradykinin- (A) and saline-treated (B) animals. C Fos
expression in the ventrolateral medulla oblongata in the (peri-)ambiguus area induced by pericardial application of
bradykinin. D High-power magnification of C.
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Fig. 7. Photomicrographs of the NTS illustrating the Fos expression
in control (A), bradykinin- (B) and capsaicin-treated (C) animals.
A, B Fos-ir at the intermediate NTS level. C High-power magnifica-
tion of Fos-ir in the caudal visceral sensory part of the right NTS after
infusion of capsaicin into the pericardial sac.
Fig. 8. Photomicrographs illustrating induction of Fos-ir in
the thoracic spinal cord after infusions of saline (A) and bra-
dykinin (B) into the pericardial sac. Note: capsaicin was not
capable of inducing Fos-ir in the thoracic segments and pro-
duced control-like images as shown in A. C Fos-ir in thoracic
segment 2 after infusion of a 3-fold increased volume of the
capsaicin solution (150 instead of 50 Ìl).
Bradykinin significantly increased Fos-ir in the central
part of the nucleus of the solitary tract (NTS) (fig. 7B), the
caudal parvocellular reticular formation, the raphe palli-
dus, the periambiguus nucleus (fig. 6C, D), and in the ros-
tral and caudal ventrolateral reticular formation (fig. 3J–
L). In addition, the extern cuneate, the cuneate, the inter-
polar and caudal spinal trigeminal nuclei showed in-
creased Fos-ir after bradykinin administration (fig. 3K,
L). A few Fos-positive cells were located in the lateral dor-
sal motor vagus nucleus.
Fos expression in the spinal cord was increased in the
dorsal laminae at the upper cervical levels and in the
upper thoracic segments, particularly in the medial parts
of laminae I–IV of the first 6 thoracic segments (fig. 3M).
Most neurons expressing Fos-ir were situated in the me-
dial parts of layers II and III of the thoracic cord (fig. 8B).
The intermediolateral cell group and the dorsal spinal
nucleus, located near the spinal canal, contained a few
Fos-positive cells. Medial and lower thoracic segments
showed small alterations of basal Fos expression after
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pericardial bradykinin administration. It was slightly in-
creased in layers I–IV of the first lumbar levels.
Fos Expression after Pericardial Capsaicin
A more generalized increase in Fos expression was
found after pericardial administration of capsaicin. The
majority of regions showing Fos-ir following bradykinin
infusions were also stained through capsaicin. The number
of Fos-positive cells in the regions, however, was higher in
many areas, including the NTS (fig. 7C), the LC, the subre-
gions of the PAG, the paraventricular hypothalamic
(fig. 5C) and thalamic nuclei, and the Acg (see quantifica-
tion). Interestingly, large parts of the ventrolateral thalam-
ic complex were Fos negative after administration of cap-
saicin, as has already been demonstrated in the bradykinin
group. The SFPC, the VPLpc, the VPMpc, and the posteri-
or thalamic nucleus, however, showed a moderately in-
creased Fos labelling. Many cortical regions which were
not or only slightly affected after pericardial bradykinin
administration showed a significant Fos-ir expression af-
ter capsaicin infusions, in particular the somatosensory
cortex. Fos-ir in the spinal trigeminal nucleus caudalis was
reduced compared with the bradykinin-induced expres-
sion and both the cochlear nuclei and the inferior colliculi
showed layers of Fos-expressing cells. The latter possibly is
a consequence of increased sensitivity for selective acous-
tic signals associated with arousal. Increased sensitivity of
the auditory system may also explain the increased region-
al Fos-ir pattern in the auditory cortical fields.
An important difference between capsaicin- and bra-
dykinin-induced Fos-ir was apparent in the thoracic spi-
nal cord. Capsaicin never induced increased Fos expres-
sion following pericardial administration, whereas there
was a significant effect here following infusion of bradyki-
nin (fig. 8A). To investigate whether this unresponsive-
ness results from the technique, the concentration of the
capsaicin solution, or the lack of ‘capsaicin receptors’ on
pericardial sensory afferents, capsaicin was administered
subcutaneously on the chest at different dosages, thus
stimulating sensory afferents that innervate the same der-
matome. In these experiments, independent of the dos-
age, a significantly increased Fos expression was gener-
ated in the medial parts of layers I–IV of the upper thorac-
ic segments, supporting previous studies [23] and provid-
ing evidence of capsaicin-unresponsive cardiac ‘sympa-
thetic’ sensory afferents.
Quantification of the Fos Expression 
In selective regions of the brain, previously associated
with cardiovascular regulation and pain, the number of
Fos-ir cells was quantified (table 1). In the thoracic spinal
cord, both the vehicle and capsaicin group showed a mean
number of 7 B 1 Fos-ir cells per hemisection. Bradykinin
significantly increased the number of labelled cells to 15
B 1 (p ! 0.001) in the upper thoracic segment. In the
NTS, bradykinin significantly increased the Fos-ir at –13
and –13.5 mm from bregma [vehicle: 14 B 4 and 15 B 2;
bradykinin: 59 B 12 (p ! 0.05) and 53 B 7 (p ! 0.05)].
Capsaicin-induced Fos-ir in the NTS was increased from
–12.5 to –14 mm [vehicle: 10 B 5, 14 B 4, 15 B 2, 8 B 1;
capsaicin: 47 B 20 (p ! 0.01), 144 B 3 (p ! 0.001), 128 B
13 (p ! 0.001), 94 B 18 (p ! 0.01)]. A drug-related effect
was found at –13 mm (capsaicin: 144 B 3; bradykinin: 59
B 12).
The (peri-)ambiguus area showed a significantly in-
creased Fos-ir between –12.5 and –14 mm both in the
bradykinin and capsaicin group [vehicle: 1 B 1, 7 B 2, 10
B 2, 7 B 2; bradykinin: 28 B 3 (p ! 0.001), 22 B 3 (p !
0.01), 30 B 4 (p ! 0.01), 24 B 3 (p ! 0.01); capsaicin: 18
B 4 (p ! 0.01), 19 B 4 (p ! 0.05), 23 B 2 (p ! 0.01), 29 B
3 (p ! 0.01)]. The number of Fos-ir cells in the LC was not
significantly affected by bradykinin administration, while
it was significantly increased in the medial LC in the cap-
saicin group [vehicle: 11 B 3; capsaicin: 62 B 16 (p !
0.05)]. Moreover, these animals showed significantly
more Fos-ir than the bradykinin-treated rats in the medial
and caudal LC [bradykinin: 7 B 1, 5 B 1; capsaicin: 62 B
16 (p ! 0.01), 43 B 14 (p ! 0.05)]. The rostral lateral para-
brachial area showed a significantly increased Fos expres-
sion in the bradykinin group [vehicle: 25 B 2 (p ! 0.001)],
as well as effects of the drugs [bradykinin: 86 B 7; capsai-
cin: 38 B 3 (p ! 0.001)]. Capsaicin and bradykinin signifi-
cantly increased Fos-ir in the medial and caudal PAG [ve-
hicle: 103 B 15, 72 B 12, 67 B 9; capsaicin: 204 B 19,
215 B 27 (p ! 0.001), 275 B 69 (p ! 0.001); bradykinin:
93 B 6, 160 B 8 (p ! 0.01), 177 B 11 (p ! 0.01)], but all
parts showed stronger responses in the capsaicin group
[bradykinin: 93 B 6, 160 B 8, 177 B 11; capsaicin: 204
B 19 (p ! 0.001), 215 B 27 (p ! 0.05), 275 B 69 (p !
0.01)].
Bradykinin increased the Fos-ir in the rostral paraven-
tricular thalamus nucleus [PVT; vehicle: 22 B 4; bradyki-
nin: 68 B 10 (p ! 0.01)] and capsaicin in the rostral and
caudal PVT [vehicle: 22 B 4, 17 B 2; capsaicin: 49 B 9
(p ! 0.01), 53 B 6 (p ! 0.001)]. The increases in the caudal
PVT [bradykinin: 38 B 3; capsaicin: 53 B 6 (p ! 0.01)]
and the rostral PVN [vehicle: 37 B 10; bradykinin: 38 B
3; capsaicin: 168 B 14 (p ! 0.001)] were significantly
higher in the capsaicin group. In the caudal PVN, both
groups showed a significantly increased Fos-ir [vehicle: 39
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Table 1. Quantification of Fos-ir in selective regions of the rat brain
after saline, bradykinin, and capsaicin infusion into the pericardial
sac of conscious animals
Area Control Bradykinin Capsaicin
Brainstem and thoracic spinal cord
Th2/Th3 7B1 15B1a 7B1b
NTS
–12.5 10B5 32B7 47B20a
–13 14B4 59B12a 144B3a, b
–13.5 15B2 53B7a 128B13a
–14 8B1 34B15 94B18a
–14.5 9B2 31B9 47B2
(Peri-)ambiguus
–12.5 1B1 28B3a 18B4a
–13 7B2 22B3a 19B4a
–13.5 10B2 30B4a 23B2a
–14 7B2 24B3a 29B3a
–14.5 8B4 9B1 12B3
Midbrain
LC
Rostral 17B4 6B1 33B14
Medial 11B3 7B1 62B16a, b
Caudal 8B3 5B1 43B14b
Lateral parabrachial nucleus
Rostral 25B2 86B7a 38B3b
Caudal 10B2 12B2 28B9
PAG
Rostral 103B15 93B6 204B19b
Medial 72B12 160B8a 215B27a, b
Caudal 67B9 177B11a 275B69a, b
Hypothalamus and thalamus
PVT
Rostral 22B4 68B10a 49B9
Caudal 17B2 38B2 53B6a, b
Hypothalamus
Rostral 95B10 225B19a 202B18a
Medial 83B3 212B21a 184B13a
Caudal 67B10 91B18 142B22a
PVN
Rostral 37B10 38B3 168B14a, b
Caudal 39B5 85B4a 88B10a
Forebrain
Central amygdala
Rostral 6B1 20B5 17B5
Medial 14B5 43B4a 38B4a
Caudal 10B2 46B9a 40B5a
Insular cortex
Rostral 18B3 95B18a 39B5
Caudal 22B3 80B15a 51B6a
Acg
Rostral 21B4 37B6 55B9a
Medial 13B3 23B3b 63B12a
Caudal 6B2 18B6b 49B5a
Significant effects compared with the control (a p ! 0.05) and bra-
dykinin-induced expression levels (b p ! 0.05) are indicated.
B 5; bradykinin: 85 B 4 (p ! 0.05); capsaicin: 88 B 10
(p ! 0.05)]. A gradually decreasing Fos expression was
found in the hypothalamus from rostral to caudal [vehi-
cle: 95 B 10, 83 B 3, 67 B 10; bradykinin: 225 B 19 (p !
0.001), 212 B 21 (p ! 0.001), 91 B 18; capsaicin: 202 B
18 (p ! 0.001), 184 B 13 (p ! 0.01), 142 B 22 (p ! 0.05)].
In both treatment groups the medial and caudal parts of
the central amygdala were activated [vehicle: 14 B 5, 10
B 2; bradykinin: 43 B 4 (p ! 0.01), 46 B 9 (p ! 0.05);
capsaicin: 38 B 4 (p ! 0.05), 40 B 5 (p ! 0.05)]. Bradyki-
nin nonsignificantly increased Fos-ir in the Acg (vehicle:
21 B 4, 13 B 3, 6 B 2; bradykinin: 37 B 6, 23 B 12, 18
B 6); the effect was more significant in the capsaicin
group [55 B 9 (p ! 0.05), 63 B 12 (p ! 0.01), 49 B 5 (p !
0.001)]. Group differences were found in the medial and
caudal Acg [bradykinin: 63 B 12 (p ! 0.05), 49 B 5 (p !
0.05); capsaicin: 23 B 3, 18 B 6)]. Bradykinin triggered a
selective Fos expression in the insular cortex [visceral
fields according to Swanson [62]; fig. 4F; vehicle: 18 B 3,
22 B 3; bradykinin: 95 B 18 (p ! 0.001), 80 B 15 (p !
0.01)]; capsaicin triggered Fos expression only in the cau-
dal part of the insular cortex [vehicle: 22 B 3; capsaicin:
51 B 6 (p ! 0.05)].
Discussion
The onset of angina pectoris, usually the result of isch-
emic episodes in the myocardium, is initiated through
excitation of chemosensitive and mechanoreceptive re-
ceptors in the heart. During these ischemic episodes, a
collage of chemicals is released that excites the receptors
of the sympathetic and vagal afferent pathways. Afferent
fibers from the heart and coronary arteries respond vigor-
ously to pain-inducing chemicals when applied to the epi-
cardial surface or injected directly into coronary arteries
[3, 24, 25]. In our study, cardiac pain was produced by
algesic inflammatory substances, i.e. bradykinin or cap-
saicin infusions into the pericardial sac. In general, areas
that showed an increase in Fos expression following the
induction of cardiac pain are considered to be involved in
the perception or integration of cardiac pain. A potential
initiator of Fos-ir is the cardiovascular emergency re-
sponse. The Fos expression was significantly increased in
the cardiovascular control areas [26–32], including the
NTS, the periambiguus area, the ventrolateral reticular
formation, and the parabrachial complex, the ventrolater-
al PAG, the hypothalamus, and the central amygdala. In
our study, bradykinin and capsaicin showed different
changes in cardiovascular response (fig. 2); while bradyki-
Acute Heart Pain in Conscious Rats Neurosignals 2004;13:207–226 221
nin administration was followed by an immediate but
nonsignificant rise in heart rate (heart rate was elevated
for 1 h and then followed by a slight decrease) (fig. 2A),
capsaicin caused only a slight decrease in heart rate during
the first 20 min (fig. 2C). These slight changes in the heart
rate of rats cannot induce a significant increase in Fos
expression in these cardiovascular control areas of the
brain. Furthermore, bradykinin did not generate signifi-
cant changes in mean arterial pressure, while capsaicin
generated biphasic hypertension. Hypertension has been
found to induce Fos expression in the medial NTS, the
baroreceptor strip of the commissural NTS, and the cau-
dal ventrolateral medulla [33]. However, hypertension
and noxious myocardial stimulation-induced Fos expres-
sions in the brainstem are not compatible. Therefore,
changes in cardiovascular responses cannot be responsi-
ble for a significant increase in Fos expression in our
study.
In order to further increase the significance of the
results, only those areas which showed a significant in-
crease in Fos expression following both bradykinin and
capsaicin administration were considered to be of impor-
tance in the perception and integration of cardiac noci-
ception. Table 2 summarizes the areas that showed Fos
expression in conscious rats after pericardial noxious
stimulation with bradykinin and capsaicin. Column 3 of
table 2 lists the areas that showed moderate and strong
increases in Fos expression in both groups.
Spinal Cord
Fos expression in the spinal cord was increased in the
dorsal laminae at the upper cervical levels and in the
upper thoracic segments. Sympathetic afferent fibers
from the heart enter the upper thoracic spinal cord and
synapse on the cells of origin of the ascending pathways.
These fibers generally have their cell bodies in the dorsal
root ganglia of the C8–T9 spinal segments [34, 35]. These
dorsal root ganglion cells have axons entering the tract of
Lissauer and terminating in the same segment or ascend-
ing and descending a few segments before they penetrate
into the spinal cord [36].
The upper cervical segment is an important area,
which is thought to provide a neural substrate for referred
pain originating from the heart. In our study, the upper
cervical segment also showed increased Fos expression in
the dorsal laminae. Somatic receptive fields for C1–C3
neurons are found most commonly in the areas of the
neck, jaw, ear, and upper arm. These neurons are far
removed from the entry zone of the cardiac afferent
fibers, which is primarily in the T2–T6 dorsal root ganglia
Table 2. Semiquantitative description of the Fos expression in the
rat brain after noxious myocardial stimulation with bradykinin and
capsaicin







Agranular insular cortex ++ +
Cingulate cortex ++ +++ y
Dysgranular insular cortex + +
Ectorhinal cortex – +
Entorhinal cortex + +
Frontal association cortex + +
Granular insular cortex ++ ++ y
Infralimbic cortex ++ +++ y
Parietal association cortex + ++
Perirhinal cortex – ++
Piriform cortex – ++
Prelimbic cortex ++ +++ y
Primary auditory cortex ++ +++ y
Primary motor cortex + ++
Primary somatosensory cortex ++ +++ y
Primary visual cortex ++ +++ y
Retrosplenial agranular cortex ++ +++ y
Retrosplenical granular cortex ++ +++ y
Secondary auditory cortex ++ +++ y
Secondary motor cortex + ++
Secondary somatosensory cortex ++ ++ y
Secondary visual cortex + ++
Temporal association cortex ++ +++ y
Other forebrain
Accumbens nucleus, core + –
Accumbens nucleus, shell + ++
Caudate putamen (striatum) – +
Lateral globus pallidus – –
Lateral septal nucleus ++ +
Medial globus pallidus + –
Medial septal nucleus – –
Nucleus horizontal limb diagonal band – –
Nucleus vertical limb diagonal band + ++
Subiculum + ++
Amygdala
Amygdalohippocampal area + +
Anterior cortical amygdaloid nucleus – +
Basolateral amygdaloid nucleus + ++
Basomedial amygdaloid nucleus + ++
Central amygdaloid nucleus ++ ++ y
Lateral amygdaloid nucleus – –
Medial amygdaloid nucleus ++ +++ y
Midbrain
Anterior pretectal nucleus + +
Dorsolateral periaqueductal gray ++ +++ y
Cuneiform nucleus ++ ++ y
Deep gray layer of ther superior colliculus + ++
Dorsal raphe nucleus ++ ++ y
Dorsomedial periaqueductal gray + +
Intermediate gray layer of the superior colliculus ++ +++ y
Interpeduncular nucleus + +
Lateral peraqueductal gray + +
Medial pretectal nucleus – –
Median raphe nucleus + +
Peripeduncular nucleus ++ +
Posterior pretectal nucleus – –
Red nucleus – –
+
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Table 2 (continued)







Substantia nigra – +
Ventral tegmental area ++ +
Ventral tegmental nucleus ++ –
Ventrolateral periaqueductal gray +++ +++ y
Pons
Deep meseancephalic nucleus + ++
Cortex inferior colliculus ++ ++ y
Dorsal tegmental nucleus ++ –
Dorsomedial tegmental area + ++
Kölliker-Fuse nucleus ++ ++ y
Lateral parabrachial nucleus ++ ++ y
Lateral vestibular nucleus – –
Laterodorsal tegmental nucleus ++ ++ y
Locus coeruleus – ++
Medial parabrachial nucleus + +
Medial vestibular nucleus – –
Pedunculopontine tegmental nucleus ++ ++ y
Pontine nuclei ++ +++ y
Pontine raphe nucleus + +
Pontine reticular nucleus + +
Spinal vestibular nucleus – –
Subcoeruleus nucleus – +
Superior vestibular nucleus – –
Ventral cochlear nucleus ++ ++ y
Thalamus
Anterodorsal thalamic nucleus – +
Anteromedial thalamic nucleus – ++
Anteroventral thalamic nucleus – +
Central medial thalamic nucleus ++ +++ y
Centrolateral thalamic nucleus ++ +++ y
Intergeniculate leaf +++ +++ y
Dorsal lateral geniculate nucleus – +
Lateral habenular nucleus + ++
Lateral posterior thalamic nucleus + +
Laterodorsal thalamic nucleus – –
Medial geniculate nucleus + +
Medial habenular nucleus – –
Mediodorsal thalamic nucleus + ++
Olivary pretectal nucleus + +
Paracentral thalamic nucleus – ++
Parafascicular thalamic nucleus – –
Paraventricular thalamic nucleus +++ +++ y
Posterior intralaminar thalamic nucleus ++ ++ y
Posterior thalamic nuclear group + +
Posteromedian thalamic nucleus – –
Reticular thalamic nucleus – –
Reuniens thalamic nucleus – ++
Rhomboid thalamic nucleus ++ ++ y
Submammillothalamic nucleus – –
Submedius thalamic nucleus – –
Subparafascicular thalamic nucleus ++ ++ y
Subthalamic nucleus – –
Ventral anterior thalamic nucleus – +
Ventral lateral geniculate nucleus + +
Ventral posterior thalamic nucleus – –
Ventral posterolateral thalamic nucleus ++ ++ y
Ventral posteromedial thalamic nucleus ++ ++ y
Ventrolateral thalamic nucleus – –
Ventromedial thalamic nucleus – +







Anterior hypothalamic area + +
Bed nucleus of the stria terminalis ++ ++ y
Arcuate hypothalamic nucleus + +
Dorsal hypothalamic area ++ +++ y
Dorsomedial hypothalamic nucleus ++ +++ y
Lateral hypothalamic area ++ ++ y
Lateral mammillary nucleus + +
Lateral preoptic area + ++
Lateroanterior hypothalamic nucleus + –
Medial mammillary nucleus – –
Medial preoptic nucleus + +
Median preoptic nucleus ++ +
Paraventricular hypothalamic nucleus ++ +++ y
Perifornical nucleus ++ ++ y
Posterior hypothalamic area + +
Premammillary nucleus, dorsal part + +
Premammillary nucleus, ventral part – –
Retrochiasmatic area +++ +++ y
Suprachiasmatic nucleus ++ +
Supramammillary nucleus + +
Supraoptic nucleus ++ ++ y
Ventromedial hypothalamic nucleus + ++
Zona incerta ++ ++ y
Medulla oblongata
(Peri)ambiguus nucleus ++ ++ y
Cuneate nucleus – –
Area postrema – +
Caudoventrolateral reticular nucleus ++ ++ y
Dorsal motor nucleus of vagus + +
Dorsal paragigantocellular nucleus – –
External cuneate nucleus + –
Gigantocellular reticular nucleus – –
Gracile nucleus – –
Hypoglossal nucleus – –
Inferior olive – –
Intermediate reticular nucleus ++ –
Lateral paragigantocellular nucleus + +
Lateral reticular nucleus + ++
Lateral superior olive – –
Medial superior olive ++ +
Medullary reticular nucleus, dorsal part ++ ++ y
Medullary reticular nucleus, ventral part – –
Motor trigeminal nucleus – –
Nucleus of the solitary tract +++ +++ y
Nucleus of the trapezoid body – –
Parvicellular reticular nucleus ++ +
Prepositus nucleus + +
Principal sensory trigeminal nucleus + –
Raphe magnus nucleus ++ ++ y
Raphe obscurus nucleus + +
Raphe pallidus nucleus ++ ++ y
Rostroventrolateral reticular nucleus + +
Spinal trigeminal nucleus, caudal part +++ +
Spinal trigeminal nucleus, interpolar part + +
Spinal trigeminal nucleus, oral part – –
The symbols indicate small, moderate, and significant increases of the Fos
expression in the treated groups compared with the saline control group.
Regions responding with moderate and/or strong increases in Fos expression in
both treated groups are marked with a ‘y’ in the last column. – = Lack of Fos
expression; + = small, ++ = moderate; +++ = strong increases.
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[34, 37]. It is most likely that cardiac afferent input enters
the thoracic spinal cord and ascends in the ventrolateral
quadrant of the spinal cord before it synapses on the
upper cervical segment neurons [38]. This suggestion is
based on information that excitation of neurons in the
upper thoracic spinal segment by splanchnic nerve stimu-
lation is abolished when the ventolateral part of the cord
is cut rostral to the T7 segment [38]. The splanchnic nerve
has its primary point of entry in the T9–T11 segment of the
spinal cord. This confirms the suggestion that the pool of
neurons in the upper cervical segment of the spinal cord
provides a neural substrate for referred pain originating
from the heart and perceived in the neck and jaw region
[3].
In contrast to bradykinin (fig. 8C), capsaicin never
induced increased Fos expression in the spinal cord fol-
lowing pericardial administration, while there was signifi-
cant increase in Fos expression in the upper thoracic spi-
nal cord segment when capsaicin was administrated sub-
cutaneously to the chest. Since the upper thoracic segment
is the site of entrance of the cardiac sympathetic fibers,
the lack of c-fos expression when capsaicin was used indi-
cates that pericardial infusion with capsaicin did not acti-
vate cardiac sympathetic fibers. This finding provides
evidence for capsaicin unresponsiveness to ‘sympathetic’
sensory afferents [23]. Whereas bradykinin activated the
sympathetic fibers, capsaicin most probably used the
afferents of the vagus nerve to induce the behavioral
effects of the rats. Pericardial infusion of both capsaicin
and bradykinin led to an increase in Fos expression in the
NTS. The NTS is the site of termination of the cardiac
vagal afferents, which can be activated following both
vagal or sympathetic stimulation. Since capsaicin cannot
activate cardiac sympathetic afferents, vagal activation is
the most acceptable explanation for the increase in Fos
expression in the NTS following pericardial capsaicin
administration.
Thalamus
Visceral information from the spinal segments usually
converges with input from somatic structures and ascends
to the medial and lateral thalamus [39]. Somatic pain is
mediated through the ventrobasal thalamus and selective
parts of this cell group are implicated in visceral pain
transmission [40, 41]. After pericardial noxious stimula-
tion in conscious rats, a significant increase in the Fos-
labeled cells was found in the VPLpc, the VPMpc, the
SFPC, and the medial nuclei of the thalamus (fig. 4A, B).
The VPLpc and the VPMpc both project to the posteri-
or, granular and agranular insular cortex [42], which has-
been recognized as the visceral sensory cortex [43]. Com-
pared with the significantly increased Fos expression in
the insular cortex, the number of Fos-positive cells in the
ventroposterior thalamus was small. Limited thalamic
Fos expression was also found in anesthetized animals
after visceral or superficial noxious stimulation [18]. This
suggests that alternative pathways may mediate visceral
pain signals to the cerebral cortex.
Based on our observations, we suggest SFPC as an
alternative thalamic region for the transmission of viscer-
al pain to the cerebral cortex. Efferents originating from
the SFPC innervate the limbic forebrain [44], the PAG
[45], and the spinal cord [44]. This wide pattern of inner-
vation does not support a selective role for the SFPC in
thalamocortical pain transmission. Most likely, SFPC
plays a crucial role in circuitry for emotional coping
responses and/or pain.
The midline dorsal thalamic nuclei were also affected
by noxious myocardial stimulation and accordingly they
can relay the signal to the visceral sensory cortex. The
paraventricular, the centrolateral, the centromedial, and
the rhomboid midline thalamic nuclei, all showing in-
creased Fos expression after noxious myocardial stimula-
tion, maintain reciprocal connections with the cortical
and subcortical limbic nuclei, including the amygdala, the
hippocampus, the hypothalamus, the nucleus accumbens,
and the prefrontal cortex [46]. Afferents of the midline
dorsal thalamus originate from the PAG [47], the LC,
Barrington’s nucleus, the raphe, the parabrachial com-
plex, and the NTS [48]. This connectivity implies that the
midline thalamic nuclei are crucial in the central integra-
tion of pain perception.
Limbic System
We found an increased Fos expression in the prelimbic
cortex, the infralimbic cortex, the anterior cingulate gy-
rus, the hypothalamus, and the amygdala after induction
of acute inflammatory heart pain in conscious rats. The
Fos expression in the cingulate gyrus decreased from ros-
tral to caudal, in line with previous investigations that
have implied the role of the rostral human cingulate gyrus
in adverse emotional responses to pain [49, 50]. Visceral
pain has a stressful effect on rats, and as such is associated
with a limbic system-mediated motor response. Accord-
ingly, the main behavioral response types shown during
acute heart pain were chest scratching and long-term
immobilization. The limbic cortex areas most likely per-
form functions that are related to the planning and coordi-
nation of the behavioral and neuroendocrine stress re-
sponses [50, 51]. A cardiomotor function was demon-
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strated for the anterior cingulate gyrus and for insular cor-
tex [30–32].
The caudal cingulate gyrus has been implicated in the
initiation of avoidance reactions that involve attention-
demanding cognitive tasks [49, 50]. It is tempting to spec-
ulate that increased Fos expression in the caudal cingulate
cortex represents avoidance-learning behavior in con-
scious rats. Avoidance responses have a survival value. A
typical example of an avoidance reaction to adverse vis-
ceral stimulation is the rejection of toxic foods. In hu-
mans, pain-inducing coronary artery obstruction(s) or va-
sospasms can be avoided to some extent. Patients with
coronary artery disease will learn an appropriate with-
drawal response after repeated attacks. By avoiding stress
and exertion, these patients can reduce the intensity and
duration of the anginal pain [1].
Increased infralimbic activity after noxious myocar-
dial stimulation may be related to the ‘visceral motor
function’ ascribed to this cortical field [52]. Execution of
visceral motor activity by the infralimbic cortex involves
the hypothalamus, the area that relays the output of the
limbic forebrain to the autonomic nervous system [53].
The main output area of the hypothalamus is the paraven-
tricular nucleus [53]. Efferents from the PVN distribute
information to the pituitary neuroendocrine system, and
the preganglionic parasympathetic and sympathetic cell
groups in the brainstem and spinal cord [53, 54]. In stress-
ful situations, the activation of the PVN is important for
emotional expression, in particular for the cardiovascular
responses.
Cells expressing corticotropin-releasing hormone are
located in the PVN and mediate glucocorticoid feedback
to the hypothalamo-pituitary-adrenal and limbic system
[55]. The central amygdala also controls cardiovascular
and neuroendocrine activity [31, 53, 56] and accordingly
showed increased Fos expression after myocardial nox-
ious stimulation. Like the PVN, corticotropin-releasing-
hormone-positive cells in the central amygdala may exert
a glucocorticoid feedback to the limbic forebrain system
and the regions involved in modulation of autonomic
functions. PET studies showed hypothalamic and hippo-
campal gyrus (including the amygdala) activation in pa-
tients with coronary artery disease during dobutamine-
induced heart pain [1, 57], confirming increased hypotha-
lamic and amygdaloid Fos expression after induction of
acute heart pain in rats.
Descending Pain Control
The PAG, the LC, and the raphe nuclei all showed an
increased Fos expression after the noxious myocardial
stimulation. The increase in Fos activity in these centers
does not necessarily indicate that these areas are nocicep-
tive receptive centers. c-fos is a marker of neuronal activi-
ty which can be activated following different modes of
stimuli, including nonnociceptive stimulation [26–32]. In
another study in rats, electrical stimulation using TENS
(transcutaneous electrical nerve stimulation) showed an
increase in c-fos activity in different cardiovascular cen-
ters of the brain although the rats which had been stimu-
lated did not show pain behavior [58]. Clinically this
mode of stimulation has a beneficial effect on patients
with refractory angina pectoris.
Since descending projections from these regions partic-
ipate in pain modulation [59], the increase in c-fos activi-
ty in these areas is most likely related to the descending
pain modulation in response to the nociceptive stimulus.
Electrical stimulation of the PAG suppresses nociception-
associated activity of the dorsal horn neurons, including
the spinothalamic tract cells [60, 61]. The PAG is com-
prised of longitudinally oriented columns with different
roles in pain control [62], for example the ventrolateral
and lateral PAG, affected most by the noxious myocardial
stimulation in awake rats, mediate opioid and nonopioid
analgesia, respectively [62]. Descending projections from
the LC and raphe nuclei have been associated with so-
called gate control [59] – a theory that provides a model to
explain modalities of the ascending pain-relaying systems
by influencing interneurons at the spinal level, and the
flow of information to the pain-processing systems in the
forebrain. The raphe magnus has selective ‘pain-on’ and
‘pain-off’ cells [63] and innervates, like the LC, the thorac-
ic spinal substantia gelatinosa, and the NTS [59, 64, 65],
the regions that receive the input from the cardiac noci-
ceptors. Physical and psychological stress also generate
LC and raphe cell activity [66, 67], which may imply the
role of stress as a pathophysiological factor in the develop-
ment of cardiovascular diseases.
Possible Limitation
Motor behavior was most likely not an important ini-
tiator of the Fos expression since the animals, as a conse-
quence of pain perception, remained immobilized most
of the time. Accordingly, the Fos expression in the motor
cortex and the basal ganglia was not increased after peri-
cardial noxious stimulation.
In conclusion, noxious pericardial stimulation in
awake rats is the most realistic angina model available
today. It is likely that making use of such models will
enable researchers to answer fundamental questions relat-
ed to the pathways of cardiac pain.
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